For the treatment of type 2 diabetes, empagliflozin should be ...
the preferred first line therapy (instead of metformin).
the preferred first add-on therapy with metformin.
a favorably considered add-on therapy.
a third or fourth line therapy after more traditional options.
Total votes: 31



What's New


Succinct reviews that discuss the potential impact of recently published manuscripts on ambulatory care pharmacy practice. Read the commentaries and voice your own opinions.


Our unique Case Studies concentrate on ambulatory care practice topics. Come take a case study and see expert opinion answers.



The iForumRx Discussion Forum is a place where any aspect of ambulatory pharmacy practice can be discussed.


Information about standards of care, practice models, building a practice, evidence-based medicine, and more.


Annotated bibliographies regarding the key clinical practice guidelines and landmark trials that should guide patient care decisions.



In these multimedia presentations, our moderator reviews a research manuscript and an expert panel discusses its strengths, weaknesses, and potential implications for practice.